Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Battermann

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
European Urology|August 30, 2008
External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patientsIlze E W van Onna, Jorg R Oddens, Esther T Kok, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2010
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancerEllen M A Roeloffzen, Irene M Lips, Marion P R van Gellekom, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Cataract after total body irradiation and bone marrow transplantation: degree of visual impairmentM Loes van Kempen-Harteveld, Henk Struikmans, Henk B Kal, et al.
BJU International|December 18, 2003
Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary resultsM Van Vulpen, A A C De Leeuw, B W Raaymakers, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parametersM L van Kempen-Harteveld, H Struikmans, H B Kal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
European Urology|August 30, 2008
External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patientsIlze E W van Onna, Jorg R Oddens, Esther T Kok, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2010
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancerEllen M A Roeloffzen, Irene M Lips, Marion P R van Gellekom, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Cataract after total body irradiation and bone marrow transplantation: degree of visual impairmentM Loes van Kempen-Harteveld, Henk Struikmans, Henk B Kal, et al.
BJU International|December 18, 2003
Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary resultsM Van Vulpen, A A C De Leeuw, B W Raaymakers, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parametersM L van Kempen-Harteveld, H Struikmans, H B Kal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Pageof 11